TECH - Bio-Techne Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1291212
Avg. Estimate0.550.521.992.41
Low estimate0.530.481.982.14
High estimate0.570.5523.56
Year ago EPS0.510.441.971.99
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1171313
Avg. Estimate308.72M302.12M1.14B1.28B
Low estimate304.5M292.9M1.14B1.21B
High estimate312.7M313.3M1.15B1.31B
Year ago sales288.23M269.65M1.11B1.14B
Sales growth (year/est)7.10%12.00%3.50%11.70%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS0.520.590.620.53
Actual EPS0.510.440.470.53
Difference-0.01-0.15-0.150
Surprise %-1.90%-25.40%-24.20%0.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate0.550.521.992.41
7 days ago0.550.521.992.41
30 days ago0.570.542.012.38
60 days ago0.570.532.012.36
90 days ago0.570.532.012.37
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1122
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesTECHIndustrySector(s)S&P 500
Current qtr.7.80%N/AN/AN/A
Next qtr.18.20%N/AN/AN/A
Current year1.00%N/AN/AN/A
Next year21.10%N/AN/AN/A
Next 5 years (per annum)10.60%N/AN/AN/A
Past 5 years (per annum)15.84%N/AN/AN/A